BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21849769)

  • 1. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
    Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
    Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    South AP; O'Toole EA
    Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
    Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
    Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
    Otte HG; Stieler W; Anton-Lamprecht I
    Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel COL7A1 splice site mutation in severe generalized recessive dystrophic epidermolysis bullosa.
    Jeon IK; Kim SE; Kim SC
    J Dermatol; 2014 Apr; 41(4):350-1. PubMed ID: 24533879
    [No Abstract]   [Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma.
    Perez-Naranjo L; Herrera-Saval A; Garcia-Bravo B; Perez-Bernal AM; Camacho F
    Arch Dermatol; 2005 Jan; 141(1):110-1. PubMed ID: 15655164
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotype-phenotype correlation in non-Hallopeau-Siemens recessive dystrophic epidermolysis bullosa: the splice site mutation c.6216+5G > T in the COL7A1 gene results in aberrant and normal splicings.
    Hamada T; Fukuda S; Ishii N; Sakaguchi S; Ishikawa T; Abe T; Yasumoto S; Hashimoto T; Nakano H; Sawamura D
    J Dermatol Sci; 2008 May; 50(2):147-50. PubMed ID: 18207370
    [No Abstract]   [Full Text] [Related]  

  • 8. [Localised de novo dominant dystrophic epidermolysis bullosa].
    Bursztejn AC; Pinault AL; Le Louarn Y; Lacour JP; Charlesworth A; Meneguzzi G; Truchetet F
    Ann Dermatol Venereol; 2008 Mar; 135(3):195-9. PubMed ID: 18374850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In this issue: glycine substitution mutations in the COL7A1 gene: implications for inheritance of dystrophic epidermolysis bullosa - dominant vs. recessive.
    Uitto J
    Acta Derm Venereol; 2011 May; 91(3):259-61. PubMed ID: 21547333
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural gene therapy in dystrophic epidermolysis bullosa.
    van den Akker PC; Nijenhuis M; Meijer G; Hofstra RM; Jonkman MF; Pasmooij AM
    Arch Dermatol; 2012 Feb; 148(2):213-6. PubMed ID: 22004882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygous mutations p.Q1530X and 6103delG in COL7A1 causing recessive dystrophic epidermolysis bullosa in a Pakistani family.
    Shaiq PA; Klausegger A; Bauer JW; Azam M; Raja GK; Qamar R
    J Dermatol; 2012 May; 39(5):472-4. PubMed ID: 21967228
    [No Abstract]   [Full Text] [Related]  

  • 12. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Wong A; Nanda A; Moss C; Martinéz AE; Mellerio JE; McGrath JA
    Acta Derm Venereol; 2011 May; 91(3):262-6. PubMed ID: 21448560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
    Kim M; Murrell DF
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational founder effect in recessive dystrophic epidermolysis bullosa families from Southern Tunisia.
    Ben Brick AS; Laroussi N; Mesrati H; Kefi R; Bchetnia M; Lasram K; Ben Halim N; Romdhane L; Ouragini H; Marrakchi S; Boubaker MS; Meddeb Cherif M; Castiglia D; Hovnanian A; Abdelhak S; Turki H
    Arch Dermatol Res; 2014 May; 306(4):405-11. PubMed ID: 24170138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
    von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
    Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
    Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
    J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
    J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
    Dang N; Murrell DF
    Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa.
    Rokunohe A; Nakano H; Aizu T; Kaneko T; Nakajima K; Ikenaga S; Matsuzaki Y; Murai T; Tamai K; Sawamura D
    J Dermatol; 2008 Jun; 35(6):336-40. PubMed ID: 18578710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the position of the premature termination codon in COL7A1 correlate with the clinical severity in recessive dystrophic epidermolysis bullosa?
    Ishiko A; Masunaga T; Ota T; Nishikawa T
    Exp Dermatol; 2004 Apr; 13(4):229-33. PubMed ID: 15086338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.